• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Tg(Grm1)转基因小鼠:一种模拟人类自发性葡萄膜黑色素瘤的小鼠模型?

Tg(Grm1) transgenic mice: a murine model that mimics spontaneous uveal melanoma in humans?

作者信息

Schiffner Susanne, Braunger Barbara M, de Jel Miriam M, Coupland Sarah E, Tamm Ernst R, Bosserhoff Anja K

机构信息

University of Regensburg, Institute of Pathology, Molecular Pathology, Franz-Joseph-Strauss-Allee 11, 93053 Regensburg, Germany.

University of Regensburg, Institute of Human Anatomy and Embryology, Universitaetsstraße 31, 93053 Regensburg, Germany.

出版信息

Exp Eye Res. 2014 Oct;127:59-68. doi: 10.1016/j.exer.2014.07.009. Epub 2014 Jul 19.

DOI:10.1016/j.exer.2014.07.009
PMID:25051141
Abstract

Although rare, uveal melanoma (UM) is the most common primary intraocular tumor in adults. About half of UM patients develop metastatic disease typically in the liver and die within a short period, due to ineffective systemic therapies. UM has unique and distinct genetic features predictive of metastasis. Animal models are required to improve our understanding of therapeutic options in disseminated UM. Since spontaneous murine UM models are lacking, our aim was to analyze the suitability of the established transgenic melanoma mouse model Tg(Grm1) as a new UM model system. We demonstrated that adult Grm1 transgenic mice develop choroidal thickening and uveal melanocytic neoplasia with expression of the melanocytic markers S100B and MelanA. Further, we showed that GRM1 is expressed in human UM, similar to skin melanoma. This study presents a new mouse model for spontaneous UM and suggests that the glutamate signaling pathway is a possible target for UM therapy.

摘要

尽管葡萄膜黑色素瘤(UM)较为罕见,但它是成人最常见的原发性眼内肿瘤。由于全身治疗无效,约一半的UM患者会发生转移性疾病,通常转移至肝脏,并在短时间内死亡。UM具有独特且明显的预测转移的基因特征。需要动物模型来增进我们对播散性UM治疗选择的理解。由于缺乏自发的小鼠UM模型,我们的目的是分析已建立的转基因黑色素瘤小鼠模型Tg(Grm1)作为一种新的UM模型系统的适用性。我们证明成年Grm1转基因小鼠出现脉络膜增厚和葡萄膜黑素细胞肿瘤形成,并表达黑素细胞标志物S100B和MelanA。此外,我们表明GRM1在人类UM中表达,类似于皮肤黑色素瘤。本研究提出了一种新的自发性UM小鼠模型,并表明谷氨酸信号通路可能是UM治疗的一个靶点。

相似文献

1
Tg(Grm1) transgenic mice: a murine model that mimics spontaneous uveal melanoma in humans?Tg(Grm1)转基因小鼠:一种模拟人类自发性葡萄膜黑色素瘤的小鼠模型?
Exp Eye Res. 2014 Oct;127:59-68. doi: 10.1016/j.exer.2014.07.009. Epub 2014 Jul 19.
2
Highly pigmented Tg(Grm1) mouse melanoma develops non-pigmented melanoma cells in distant metastases.高色素 Tg(Grm1) 鼠黑色素瘤在远处转移中发展出非色素性黑色素瘤细胞。
Exp Dermatol. 2012 Oct;21(10):786-8. doi: 10.1111/j.1600-0625.2012.01560.x. Epub 2012 Aug 7.
3
Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia.黑色素瘤小鼠模型表明代谢型谷氨酸信号传导与黑素细胞肿瘤形成有关。
Nat Genet. 2003 May;34(1):108-12. doi: 10.1038/ng1148.
4
Grm5 expression is not required for the oncogenic role of Grm1 in melanocytes.Grm5的表达对于Grm1在黑素细胞中的致癌作用并非必需。
Neuropharmacology. 2005;49 Suppl 1:70-9. doi: 10.1016/j.neuropharm.2005.05.018.
5
Metabotropic glutamate receptor subtype-1 is essential for in vivo growth of melanoma.代谢型谷氨酸受体亚型1对黑色素瘤的体内生长至关重要。
Oncogene. 2008 Dec 4;27(57):7162-70. doi: 10.1038/onc.2008.329. Epub 2008 Sep 8.
6
Differential expression of Mart-1 in human uveal melanoma cells.人葡萄膜黑色素瘤细胞中 Mart-1 的差异表达。
Mol Med Rep. 2011 Sep-Oct;4(5):799-803. doi: 10.3892/mmr.2011.504. Epub 2011 Jun 7.
7
Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma.代谢型谷氨酸受体1与人类黑色素瘤中的谷氨酸信号传导
Cancer Res. 2007 Mar 1;67(5):2298-305. doi: 10.1158/0008-5472.CAN-06-3665.
8
Glutamatergic signaling in cellular transformation.谷氨酸能信号在细胞转化中的作用。
Pigment Cell Melanoma Res. 2012 May;25(3):331-42. doi: 10.1111/j.1755-148X.2012.00983.x. Epub 2012 Feb 20.
9
Expression of nm23-H1 in uveal melanoma.nm23-H1在葡萄膜黑色素瘤中的表达。
Melanoma Res. 2007 Oct;17(5):284-90. doi: 10.1097/CMR.0b013e3282eeea5a.
10
Functional effects of GRM1 suppression in human melanoma cells.GRM1 抑制对人黑色素瘤细胞的功能影响。
Mol Cancer Res. 2012 Nov;10(11):1440-50. doi: 10.1158/1541-7786.MCR-12-0158. Epub 2012 Jul 13.

引用本文的文献

1
Modeling a mesenchymal cell state by bioprinting for the molecular analysis of dormancy in melanoma.通过生物打印模拟间充质细胞状态用于黑色素瘤休眠的分子分析
Mater Today Bio. 2025 Mar 18;32:101674. doi: 10.1016/j.mtbio.2025.101674. eCollection 2025 Jun.
2
Transcription factor activating enhancer-binding protein 2ε (AP2ε) modulates phenotypic plasticity and progression of malignant melanoma.转录因子激活增强子结合蛋白 2ε(AP2ε)调节恶性黑色素瘤的表型可塑性和进展。
Cell Death Dis. 2024 May 21;15(5):351. doi: 10.1038/s41419-024-06733-3.
3
Bone Morphogenetic Protein 13 Has Protumorigenic Effects on Hepatocellular Carcinoma Cells In Vitro.
骨形态发生蛋白 13 在体外对肝癌细胞具有促肿瘤作用。
Int J Mol Sci. 2023 Jul 4;24(13):11059. doi: 10.3390/ijms241311059.
4
Cold Atmospheric Plasma Triggers Apoptosis via the Unfolded Protein Response in Melanoma Cells.冷大气等离子体通过黑色素瘤细胞中的未折叠蛋白反应触发细胞凋亡。
Cancers (Basel). 2023 Feb 7;15(4):1064. doi: 10.3390/cancers15041064.
5
Alpha-Synuclein and Its Role in Melanocytes.α-突触核蛋白及其在黑素细胞中的作用。
Cells. 2022 Jun 30;11(13):2087. doi: 10.3390/cells11132087.
6
Detection of Cellular Senescence in Human Primary Melanocytes and Malignant Melanoma Cells In Vitro.体外检测人原代黑素细胞和恶性黑素瘤细胞中的细胞衰老。
Cells. 2022 Apr 28;11(9):1489. doi: 10.3390/cells11091489.
7
Aggressive uveal melanoma displays a high degree of centrosome amplification, opening the door to therapeutic intervention.侵袭性葡萄膜黑色素瘤表现出高度的中心体扩增,为治疗干预开辟了道路。
J Pathol Clin Res. 2022 Jul;8(4):383-394. doi: 10.1002/cjp2.272. Epub 2022 Apr 26.
8
Animal Models of Uveal Melanoma.葡萄膜黑色素瘤的动物模型
Ann Eye Sci. 2022 Mar;7. doi: 10.21037/aes-21-30. Epub 2022 Mar 15.
9
Impact of on chromatin structure and histone methylation in malignant melanoma.对恶性黑色素瘤染色质结构和组蛋白甲基化的影响。
Int J Mol Med. 2022 May;49(5). doi: 10.3892/ijmm.2022.5122. Epub 2022 Mar 16.
10
Nanotechnology Addressing Cutaneous Melanoma: The Italian Landscape.纳米技术与皮肤黑色素瘤:意大利的情况
Pharmaceutics. 2021 Oct 4;13(10):1617. doi: 10.3390/pharmaceutics13101617.